Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study

Abstract Cerebral amyloid angiopathy (CAA) is a common yet underdiagnosed disease of the small brain vessels, resulting in acute vascular events as well as subcortical neurodegeneration. Currently, it is identified only at advanced stages due to the limitations of non-invasive diagnostic tools. Our...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, Daniel Farrenkopf, Ulrike J. Naumann, Kilian Fröhlich, Jochen A. Sembill, Martin F. Fromm, Stefan Schwab, Veit Rothhammer, Joji B. Kuramatsu, Anne Mrochen
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-12-01
Col·lecció:	Scientific Reports
Matèries:	Cerebral amyloid angiopathy Metabolomics Immunphenotyping Caffeine pathway
Accés en línia:	https://doi.org/10.1038/s41598-025-31107-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!